Comparative susceptibilities of Campylobacter pylori to norfloxacin and other agents
- 1 June 1987
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 31 (6), 949-950
- https://doi.org/10.1128/aac.31.6.949
Abstract
Twenty-one strains of Campylobacter pylori (Campylobacter pyloridis) were tested for susceptibility to norfloxacin and other agents by the serial agar dilution method. Ampicillin (MIC for 90% of isolates [MIC90], 0.016 micrograms/ml) and famotidine (MIC90, greater than 1,024 micrograms/ml) were, respectively, the most and the least active of the agents tested. Norfloxacin (MIC90, 1 microgram/ml) and imipenem (MIC90, 0.125 micrograms/ml) were substantially active against this organism.This publication has 10 references indexed in Scilit:
- FamotidineDrugs, 1986
- UREA HYDROLYSIS IN PATIENTS WITH CAMPYLOBACTER PYLORIDIS INFECTIONThe Lancet, 1986
- Relation of Campylobacter pyloridis to Gastritis and Peptic UlcerThe Journal of Infectious Diseases, 1986
- The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridisJournal of Antimicrobial Chemotherapy, 1986
- Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1985
- Characterization of "Campylobacter pyloridis" by culture, enzymatic profile, and protein contentJournal of Clinical Microbiology, 1985
- Norfloxacin A Review of Its Antibacterial Activity, Pharmacokinetic Properties and Therapeutic UseDrugs, 1985
- Pyloric Campylobacter infection and gastroduodenal diseaseThe Medical Journal of Australia, 1985
- UNIDENTIFIED CURVED BACILLI IN THE STOMACH OF PATIENTS WITH GASTRITIS AND PEPTIC ULCERATIONThe Lancet, 1984